Form 4: Cidara CMO Gifts Shares to Charity

Cidara Therapeutics' Chief Medical Officer, Nicole Negar Davarpanah, gifted 450 shares of common stock to a donor-advised fund for charitable purposes.

Summary

• Nicole Negar Davarpanah, Chief Medical Officer of Cidara Therapeutics, Inc. (CDTX), reported a change in beneficial ownership.
• On December 29, 2025, Davarpanah disposed of 450 shares of common stock through a bona fide gift to a donor-advised fund for charitable purposes.
• The reporting person retains no beneficial ownership or control over the donated securities following the contribution.
• Following this transaction, Davarpanah beneficially owns 20,886 shares of Cidara Therapeutics common stock.
• This total includes 50 shares acquired on December 18, 2025, through the Issuer's Employee Stock Purchase Plan (ESPP).

Sentiment

Score: 5

Explanation: The filing reports a personal transaction by an insider, a charitable gift of shares, which is neutral in terms of company performance or outlook.

Positives

• The Chief Medical Officer engaged in charitable giving by donating 450 shares to a donor-advised fund, demonstrating personal philanthropy.

Negatives

• No direct negative financial implications for Cidara Therapeutics were reported in this filing.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: A very minor reduction in insider ownership due to a charitable gift, which is unlikely to have a material impact on company valuation or operations.

Key Dates

Recommendation

This Form 4 reports a charitable gift of a relatively small number of shares by a Chief Medical Officer. Such a transaction is a personal financial decision and does not reflect on the operational performance or future prospects of Cidara Therapeutics, Inc. Therefore, it does not provide a basis for altering an investment recommendation.

Keywords

Cidara Therapeutics, CDTX, Form 4, Insider Transaction, Stock Gift, Charitable Donation, Chief Medical Officer, Nicole Negar Davarpanah